3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
55
Prostatic Neoplasms
46
Glioblastoma
28
Brain Neoplasms
25
Neoplasms
23
Glioma
21
Carcinoma, Non-Small-Cell Lung
19
Lung Neoplasms
18
Carcinoma, Hepatocellular
14
Gliosarcoma
13
Colorectal Neoplasms
12
Uterine Cervical Neoplasms
11
Neoplasm Metastasis
11
Rectal Neoplasms
10
Lymphoma, Non-Hodgkin
10
Oligodendroglioma
9
Melanoma
9
Central Nervous System Neoplasms
9
Astrocytoma
9
Lymphoma
8
Head and Neck Neoplasms
8
Esophageal Neoplasms
8
Colonic Neoplasms
8
Ependymoma
7
Squamous Cell Carcinoma of Head and Neck
6
Pancreatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Carcinoma, Renal Cell
6
Breast Neoplasms, Male
6
Ovarian Neoplasms
5
Interventions
Cyclophosphamide
2
pembrolizumab
1
napabucasin
1
guadecitabine
1
Sutures
1
Surgical Instruments
1
Pemetrexed
1
Oxaliplatin
1
Oviposition
1
Ocoxin
1
Magnetic Resonance Spectroscopy
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Drainage
1
Colonoscopy
1
Cetuximab
1
Capecitabine
1
Bevacizumab
1
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rectal Diseases
×
Magnetic Resonance Spectroscopy
×
Clear all
NCT01816607
2018-11-19
OxyTarget
University Hospital, Akershus
Completed
192 enrolled